RemeGen Co., Ltd. (9995.HK)

HKD 15.52

(-0.26%)

Revenue Summary of RemeGen Co., Ltd.

RemeGen Co., Ltd.'s latest annual revenue in 2023 was 1.07 Billion CNY , up 40.16% from previous year.
RemeGen Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 411.32 Million CNY , up 24.48% from previous quarter.
RemeGen Co., Ltd. reported a annual revenue of 767.77 Million CNY in annual revenue 2022, down -46.08% from previous year.
RemeGen Co., Ltd. reported a annual revenue of 1.42 Billion CNY in annual revenue 2021, down 0.0% from previous year.
RemeGen Co., Ltd. reported a quarterly revenue of 330.43 Million CNY for 2024 Q1, up 5.41% from previous quarter.
RemeGen Co., Ltd. reported a quarterly revenue of 350.39 Million CNY for 2023 Q3, up 37.85% from previous quarter.

Annual Revenue Chart of RemeGen Co., Ltd. (2023 - 2018)

Historical Annual Revenue of RemeGen Co., Ltd. (2023 - 2018)

Year	Revenue	Revenue Growth
2023	1.07 Billion CNY	40.16%
2022	767.77 Million CNY	-46.08%
2021	1.42 Billion CNY	0.0%
2020	- CNY	0.0%
2019	- CNY	-100.0%
2018	11.32 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q2	411.32 Million CNY	24.48%
2024 Q1	330.43 Million CNY	5.41%
2023 Q3	350.39 Million CNY	37.85%
2023 FY	1.07 Billion CNY	40.16%
2023 Q4	313.48 Million CNY	-10.53%
2023 Q2	254.18 Million CNY	51.09%
2023 Q1	168.23 Million CNY	-15.09%
2022 Q3	220.85 Million CNY	10.3%
2022 Q1	150.13 Million CNY	-88.53%
2022 Q2	200.23 Million CNY	33.37%
2022 FY	767.77 Million CNY	-46.08%
2022 Q4	198.13 Million CNY	-10.29%
2021 Q3	85.31 Million CNY	242.49%
2021 Q1	4.28 Million CNY	0.0%
2021 FY	1.42 Billion CNY	0.0%
2021 Q2	24.91 Million CNY	481.81%
2021 Q4	1.3 Billion CNY	1434.78%
2020 Q3	- CNY	0.0%
2020 Q4	- CNY	0.0%
2020 Q2	- CNY	0.0%
2020 Q1	- CNY	0.0%
2020 FY	- CNY	0.0%
2019 Q1	- CNY	0.0%
2019 FY	- CNY	-100.0%
2019 Q4	- CNY	0.0%
2019 Q3	- CNY	0.0%
2019 Q2	- CNY	0.0%
2018 Q4	- CNY	0.0%
2018 Q2	2.83 Million CNY	0.0%
2018 Q1	2.83 Million CNY	0.0%
2018 FY	11.32 Million CNY	0.0%
2017 Q4	2.83 Million CNY	0.0%

Peer Revenue Comparison of RemeGen Co., Ltd.

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	-122.012%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	79.782%